agement, he served as Managing Director, and co-founder of MPM's Asset Management's first fund. Prior to MPM, Dr. Bremer served as Fund Manager for BB Biotech where he grew BB Biotech from >$300 to >$1,000 million in net asset value while achieving +21% returns over the course of four years. DACAR T C. A